Tianasen

ASO-GNAO1

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tianasen, covering 2026-01-23 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. [Phase 1, Phase 2]